Patient care & support

Latest statement by neuromuscular clinicians: COVID vaccines are safe

Many people in our community have concerns about receiving the COVID-19 vaccine, and whether complications can arise for people who take immunosuppressants. In response, four neuromuscular experts have confirmed that the COVID-19 vaccines are safe, and are encouraging people over the age of 16 with DMD to take it as soon as possible. Please read their statement below.

As of yet, approval has not been given for young people under 16 to receive the vaccine. Young people under 16 should only receive the vaccine under specific advice from their clinician or GP.

Advice from Professor Francesco Muntoni, Professor Ros Quinlivan, Dr Adnan Manzur and Dr Chiara Marini-Bettolo who are four neuromuscular experts leading the paediatric and adult North Star and SMA Reach networks of neuromuscular health professionals:

In line with the national and international guidelines, we can advise that the Pfizer/BioNTech, Moderna, and Oxford/AstraZeneca vaccine should be fine to receive for those living with a neuromuscular condition including those on immunosuppression treatments. We therefore encourage you to get vaccinated at your earliest opportunity.

Those on immunosuppression may have a reduced immune response (i.e the vaccine will be less effective) but can still have the vaccine.

In line with recent Medicines and Healthcare products Regulatory Agency (MHRA) guidance people under 30 who have had the first AstraZeneca (AZ) vaccine are advised to take the second one. People under 30 who have not had their first vaccine will be offered an alternative to the AZ vaccine. 

Please make every effort to avoid exposure to COVID-19. If you feel unwell then please seek a PCR-based test from the national testing centres. If this is positive please let your specialist teams know as soon as you can.

It is important to remember that the Medicines and Healthcare products Regulatory Agency (MHRA) would not have licenced the vaccine if there were any doubts as to its safety.

For more information please contact our team, or else you can consult the Green Book (vaccination information for public health professionals) here.

Published on 13 April 2021

Share this article
Categories Patient care & support